Overview

Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers

Status:
Unknown status

Trial end date:
2020-05-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine Safety and Efficacy of Radioactive Iodine (RAI) Treatment of Metastatic and Advanced Differentiated Thyroid Cancers by Pretreatment With Apatinib for the Neoadjuvant Regimen

Phase:

Phase 2

Details

Lead Sponsor:

Nanjing First Hospital, Nanjing Medical University

Treatments:

Apatinib